Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption

  • US 6,576,665 B2
  • Filed: 04/03/2001
  • Issued: 06/10/2003
  • Est. Priority Date: 04/03/2001
  • Status: Expired due to Term
First Claim
Patent Images

1. A composition for binding phosphorous within the gastrointestinal tract of an individual, the composition comprising:

  • a quantity of calcium acetate sufficient to bind the phosphorous in the gastrointestinal tract of the individual, the calcium acetate having a bulk density of between about 0.55 kg/L and about 0.75 kg/L, and where the quantity of calcium acetate is compressed to form a caplet for fitting within a capsule in a manner which optimizes the volume of the capsule, and where at least about 85% of said compressed calcium acetate dissolves in not more than 15 minutes when tested according to USP standard #24, test #711 at 50 to 100 RPM, apparatus 1 or 2.

View all claims

    Thank you for your feedback